These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


440 related items for PubMed ID: 21757113

  • 1. Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis).
    Blankstein R, Budoff MJ, Shaw LJ, Goff DC, Polak JF, Lima J, Blumenthal RS, Nasir K.
    J Am Coll Cardiol; 2011 Jul 19; 58(4):364-74. PubMed ID: 21757113
    [Abstract] [Full Text] [Related]

  • 2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 19; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 3. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE, Bowlin SJ, Stump TE, Sprecher DL, Tierney WM.
    Am Heart J; 2006 Mar 19; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [Abstract] [Full Text] [Related]

  • 4. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA).
    Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, Szklo M, Greenland P, Blumenthal RS.
    Circulation; 2007 Aug 07; 116(6):619-26. PubMed ID: 17646582
    [Abstract] [Full Text] [Related]

  • 5. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K, Santos RD, Roguin A, Carvalho JA, Meneghello R, Blumenthal RS.
    Int J Cardiol; 2006 Mar 22; 108(1):68-75. PubMed ID: 16516700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.
    Circulation; 2006 Mar 28; 113(12):1556-63. PubMed ID: 16534013
    [Abstract] [Full Text] [Related]

  • 9. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 01; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA, Furberg CD, O'Meara ES, Psaty BM, Kuller L, Powe NR, Manolio T.
    Circulation; 2006 May 09; 113(18):2177-85. PubMed ID: 16651468
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
    Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL.
    Circulation; 2008 Jul 08; 118(2):124-30. PubMed ID: 18591432
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA).
    Kronmal RA, McClelland RL, Detrano R, Shea S, Lima JA, Cushman M, Bild DE, Burke GL.
    Circulation; 2007 May 29; 115(21):2722-30. PubMed ID: 17502571
    [Abstract] [Full Text] [Related]

  • 19. Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors.
    Krobot KJ, Yin DD, Alemao E, Steinhagen-Thiessen E.
    Eur J Cardiovasc Prev Rehabil; 2005 Feb 29; 12(1):37-45. PubMed ID: 15703504
    [Abstract] [Full Text] [Related]

  • 20. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB, Pitsavos C, Skoumas J, Chrysohoou C, Toutouza M, Stefanadis CI, Toutouzas PK.
    Curr Med Res Opin; 2003 Feb 29; 19(2):89-94. PubMed ID: 12755140
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.